IDFC Equity Opportunity - Series 6 - Growth - Regular Plan

  • Previous Nav

  • Net Change on 16-08-2019

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The Scheme seeks to generate capital appreciation from a portfolio that is invested in equity and equity related securities of companies across market capitalization that will benefit from growth of the Indian and the global economy and in Debt and Money Market instruments maturing on or before the maturity of the scheme.However, there can be no assurance that the investment objective of the Scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE 500 -5.67 -2.47 -7.33 7.09 7.62 13.79

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Fund Holdings as on 31-July-2019

  • HDFC Bank Limited

  • GlaxoSmithKline Consumer Healthcare Limited

  • Aavas Financiers Limited

  • ITC Limited

  • Lupin Limited

  • Reliance Industries Limited

  • Larsen & Toubro Limited

  • Sun Pharmaceutical Industries Limited

  • Dr. Reddy's Laboratories Limited

  • UltraTech Cement Limited

  • ICICI Bank Limited

  • Dabur India Limited

  • Kotak Mahindra Bank Limited

  • Hindustan Unilever Limited

  • Future Retail Limited

  • Maruti Suzuki India Limited

  • Asian Paints Limited

  • 3M India Limited

  • HDFC Asset Management Company Limited

  • TVS Motor Company Limited

  • Avenue Supermarts Limited

  • Polycab India Limited

  • Emami Limited

  • Axis Bank Limited

  • Dhanuka Agritech Limited

  • Britannia Industries Limited

  • Cadila Healthcare Limited

  • Colgate Palmolive (India) Limited

  • Zydus Wellness Limited

  • PI Industries Limited

  • AIA Engineering Limited

  • Sandhar Technologies Limited

  • Triparty Repo

  • NOCIL Limited

  • Prataap Snacks Limited

  • Security and Intelligence Services (India) Limited

  • Cash Margin - CCIL

  • Net Current Assets

View More
  • Bank - Private

  • Pharmaceuticals & Drugs

  • Household & Personal Products

  • Consumer Food

  • Finance - Housing

  • Retailing

  • Cigarettes/Tobacco

  • Refineries

  • Engineering - Construction

  • Pesticides & Agrochemicals

  • Cement & Construction Materials

  • Automobiles - Passenger Cars

  • Paints

  • Diversified

  • Finance - Asset Management

  • Automobile Two & Three Wheelers

  • Cable

  • Engineering - Industrial Equipments

  • Auto Ancillary

  • Chemicals

  • Miscellaneous

View More

About IDFC Equity Opportunity - Series 6

Scheme Analysis

IDFC Equity Opportunity - Series 6 is a Equity - Multi Cap Fund fund and belongs to IDFC Mutual Fund. It was launched on 27-Jul-2018 and currently has an AUM of ₹142.91 crore. IDFC Equity Opportunity - Series 6 is benchmarked against S&P BSE 500 as primary index.

The NAV of IDFC Equity Opportunity - Series 6 ended up ₹0.02(0.21%)yesterday to ₹9.59.

Among its top 3 holdings the fund has exposure to HDFC Bank Limited, GlaxoSmithKline Consumer Healthcare Limited and Aavas Financiers Limited

The IDFC Equity Opportunity - Series 6 is managed by Anoop Bhaskar and Sumit Agrawal.

Fund House Contact

OneIndiaBulls Centre, 841, Jupiter Mills Compound, Senapati Bapat Marg, Elphinstone Road (West), Mumbai - 400 013

022-66289999
investormf@idfc.com
022-24215052
www.idfcmf.com

Fund Manager

  • Education:MBA (Finance), B.E (Mech.)
  • Experience:11
  • Basic Details:
  • Funds Managed:
  • IDFC Multi Cap Fund
  • Cash

  • Equity

View More